CAD and ACS Flashcards
What are the complications of CAD?
Angina pectoris
MI
HF
Arrhythmias
What are the modifiable major risk factors of CAD?
Elevated serum lipid levels (high LDL and low HDL)
Elevated blood pressure (BP)
Tobacco use
Physical inactivity
Obesity
What are the 2 common medication therapies used for CAD?
Cholesterol-lowering medication therapy (i.e., statins, fibrates, PCSK9 Inhibitors)
Antiplatelet therapy (i.e., aspirin)
Differentiate Chronic Stable angina from Unstable angina
Chronic Stable angina
- predictable set of symptoms that are aggravated by predictable activities
- may experience indigestion or a burning sensation in the epigastric region
Unstable angina
- chest pain that is new in onset, occurs at rest, or has a worsening pattern
- not relieved by NTG
Explain the MoA and role of NTG in managing Stable Angina
First-line therapy for chronic stable angina
Produce effects by:
1. Dilating peripheral blood vessels = reduced cardiac workload & thus reduced myocardial O2 demand
2. Dilating coronary arteries and collateral vessels
Side effects include increased HR, headache, dizziness, flushing and orthostatic hypotension
Explain the MoA and role of Beta Blockers in managing Stable Angina
decrease HR, SVR, and BP which reduces myocardial oxygen demand
Explain the MoA and role of Calcium Channel Blockers in managing Stable Angina
cause systemic vasodilation with decreased SVR, decreased myocardial contractility, and coronary vasodilation
Explain the role of Angiotensin inhibitors in managing Stable Angina
used in certain high-risk patients such as those with diabetes, significant CAD or previous MI
What is Acute Coronary Syndrome?
umbrella term for: Unstable Angina, NSTEMI, and STEMI
Associated with deterioration of an atherosclerotic plaque that was once stable
What are the clinical manifestations of a MI?
Severe pain not relieved by rest, nitroglycerin, or position change; commonly occurs in early morning hours
- Common locations are substernal, retrosternal or epigastric areas, may radiate to the back, jaw, neck or arms
shortness of breath, confusion, dizziness, skin that may be ashen, clammy, cool to touch, nausea and vomiting, fever
What are the three complications of an MI?
Dysrhythmias
Heart failure
Cardiogenic shock
What are the diagnostic studies of Unstable Angina and MI?
Serum cardiac markers – troponin, cardiac enzymes (CK)
ECG – changes in QRS complex, ST segment and T wave caused by ischemia and infarction
STEMI – may see pathological Q wave
NSTEMI or UA – usually no Q wave
Coronary angiography – evaluate the extent of disease and determine appropriate treatment modality, PCI may be performed at this time
Management of ACS
Establish IV access
Sublingual nitro and ASA
Morphine IV if pain is unrelieved by NTG
Oxygen at 2-4L/min
Continuous EKG monitoring
Vital signs
Bed rest
Anticoagulants/antiplatelets
Explain the MoA and role of Heparin in managing ACS
IV unfractionated - prevents formation of new clots
Use with unstable angina reduces the risk of MI
Bolus IV, then continuous infusion; dose based on results of aPTT
-> therapeutic range: 2- 2.5x the normal aPTT
Subcutaneous low molecular weight heparin may be used instead of IV unfractionated heparin, eliminates the need for monitoring aPTT